Trupanion (NASDAQ:TRUP) Price Target Increased to $45.00 by Analysts at Piper Sandler

Trupanion (NASDAQ:TRUP - Free Report) had its price objective raised by Piper Sandler from $38.00 to $45.00 in a research report sent to investors on Wednesday morning, Benzinga reports. They currently have a neutral rating on the financial services provider's stock.

Other analysts have also recently issued research reports about the stock. Stifel Nicolaus raised their price objective on shares of Trupanion from $30.00 to $40.00 and gave the company a hold rating in a research note on Monday, September 23rd. Northland Securities boosted their price target on Trupanion from $35.00 to $45.00 and gave the stock a market perform rating in a research note on Thursday, September 19th. Evercore ISI upgraded Trupanion to a strong-buy rating in a report on Friday, August 9th. William Blair started coverage on Trupanion in a report on Friday, July 19th. They set an outperform rating for the company. Finally, Bank of America boosted their target price on Trupanion from $47.00 to $56.00 and gave the stock a buy rating in a research report on Friday, September 20th. Four analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Trupanion presently has a consensus rating of Moderate Buy and an average target price of $41.83.

Trupanion Stock Performance

NASDAQ TRUP traded down $0.10 during trading hours on Wednesday, hitting $41.09. 442,707 shares of the stock were exchanged, compared to its average volume of 690,017. Trupanion has a 12-month low of $19.14 and a 12-month high of $49.14. The stock has a 50-day moving average of $41.91 and a 200 day moving average of $32.48. The company has a market cap of $1.73 billion, a price-to-earnings ratio of -64.20 and a beta of 1.74. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.42.

Trupanion (NASDAQ:TRUP - Get Free Report) last posted its quarterly earnings results on Thursday, August 8th. The financial services provider reported ($0.14) EPS for the quarter, beating the consensus estimate of ($0.18) by $0.04. Trupanion had a negative return on equity of 6.29% and a negative net margin of 1.57%. The business had revenue of $314.80 million during the quarter, compared to analysts' expectations of $309.33 million. During the same period last year, the firm earned ($0.33) EPS. The company's quarterly revenue was up 16.3% compared to the same quarter last year. As a group, equities research analysts forecast that Trupanion will post -0.34 earnings per share for the current year.

Insider Activity at Trupanion

In other Trupanion news, CEO Margaret Tooth sold 7,500 shares of the firm's stock in a transaction on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total transaction of $348,600.00. Following the completion of the transaction, the chief executive officer now owns 99,984 shares of the company's stock, valued at $4,647,256.32. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, CEO Margaret Tooth sold 7,500 shares of the firm's stock in a transaction that occurred on Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total transaction of $348,600.00. Following the sale, the chief executive officer now owns 99,984 shares in the company, valued at $4,647,256.32. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Fawwad Qureshi sold 624 shares of the business's stock in a transaction on Monday, August 26th. The shares were sold at an average price of $46.54, for a total value of $29,040.96. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 8,764 shares of company stock valued at $405,238. 5.50% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Trupanion

Large investors have recently bought and sold shares of the stock. Headlands Technologies LLC acquired a new stake in shares of Trupanion during the 2nd quarter worth $162,000. Blueshift Asset Management LLC purchased a new position in shares of Trupanion in the 4th quarter worth about $220,000. Oppenheimer Asset Management Inc. acquired a new position in shares of Trupanion in the 2nd quarter valued at about $235,000. Bayesian Capital Management LP purchased a new stake in shares of Trupanion during the 1st quarter worth about $253,000. Finally, Capstone Investment Advisors LLC acquired a new stake in Trupanion during the 1st quarter worth approximately $269,000.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.